The action is based on the allegation that the drug was marketed for migraine headache pain relief when the defendants knew or ought to have known that the users could easily become addicted.
A settlement has been reached with the defendants that resolves the litigation. The deadline to file a claim under the settlement was January 31, 2005. This settlement has concluded and all claims have been paid.
For further information contact Jennifer Bald at 1-800-461-6166 ext. 2455 or e-mail Jennifer by clicking on the Contact Us link below.